Tango Therapeutics is a cancer therapeutics company discovering and developing novel medicines designed to target cancer vulnerabilities beyond mutated oncogenes to deliver transformational new therapies for patients. The company uses deep DNA sequencing and CRISPR-based screening to identify targets for specific subgroups of cancer patients. Tango Therapeutics goal is to leverage the principles of synthetic lethality to find the weaknesses in cancer cells created by the genetic complexity and use them to provide a roadmap to cures.